<?xml version='1.0' encoding='utf-8'?>
<document id="31002950"><sentence text="Pharmacokinetics of dolutegravir 100 mg once daily with rifampicin."><entity charOffset="20-32" id="DDI-PubMed.31002950.s1.e0" text="dolutegravir" /><entity charOffset="56-66" id="DDI-PubMed.31002950.s1.e1" text="rifampicin" /><pair ddi="false" e1="DDI-PubMed.31002950.s1.e0" e2="DDI-PubMed.31002950.s1.e0" /><pair ddi="false" e1="DDI-PubMed.31002950.s1.e0" e2="DDI-PubMed.31002950.s1.e1" /></sentence><sentence text="Tuberculosis (TB) causes 25% of all deaths among individuals infected with human immunodeficiency virus (HIV)" /><sentence text=" Rifampicin (RIF) is a potent inducer of drug metabolizing enzymes and drug transporters, and co-administration with dolutegravir (DTG) reduces DTG exposure; this can be overcome by doubling the DTG dose to 50 mg twice daily"><entity charOffset="1-11" id="DDI-PubMed.31002950.s3.e0" text="Rifampicin" /><entity charOffset="13-16" id="DDI-PubMed.31002950.s3.e1" text="RIF" /><entity charOffset="117-129" id="DDI-PubMed.31002950.s3.e2" text="dolutegravir" /><entity charOffset="131-134" id="DDI-PubMed.31002950.s3.e3" text="DTG" /><entity charOffset="144-146" id="DDI-PubMed.31002950.s3.e4" text="DTG" /><entity charOffset="195-197" id="DDI-PubMed.31002950.s3.e5" text="DTG" /><pair ddi="false" e1="DDI-PubMed.31002950.s3.e0" e2="DDI-PubMed.31002950.s3.e0" /><pair ddi="false" e1="DDI-PubMed.31002950.s3.e0" e2="DDI-PubMed.31002950.s3.e1" /><pair ddi="false" e1="DDI-PubMed.31002950.s3.e0" e2="DDI-PubMed.31002950.s3.e2" /><pair ddi="false" e1="DDI-PubMed.31002950.s3.e0" e2="DDI-PubMed.31002950.s3.e3" /><pair ddi="false" e1="DDI-PubMed.31002950.s3.e0" e2="DDI-PubMed.31002950.s3.e4" /><pair ddi="false" e1="DDI-PubMed.31002950.s3.e0" e2="DDI-PubMed.31002950.s3.e5" /><pair ddi="false" e1="DDI-PubMed.31002950.s3.e1" e2="DDI-PubMed.31002950.s3.e1" /><pair ddi="false" e1="DDI-PubMed.31002950.s3.e1" e2="DDI-PubMed.31002950.s3.e2" /><pair ddi="false" e1="DDI-PubMed.31002950.s3.e1" e2="DDI-PubMed.31002950.s3.e3" /><pair ddi="false" e1="DDI-PubMed.31002950.s3.e1" e2="DDI-PubMed.31002950.s3.e4" /><pair ddi="false" e1="DDI-PubMed.31002950.s3.e1" e2="DDI-PubMed.31002950.s3.e5" /><pair ddi="false" e1="DDI-PubMed.31002950.s3.e2" e2="DDI-PubMed.31002950.s3.e2" /><pair ddi="false" e1="DDI-PubMed.31002950.s3.e2" e2="DDI-PubMed.31002950.s3.e3" /><pair ddi="false" e1="DDI-PubMed.31002950.s3.e2" e2="DDI-PubMed.31002950.s3.e4" /><pair ddi="false" e1="DDI-PubMed.31002950.s3.e2" e2="DDI-PubMed.31002950.s3.e5" /><pair ddi="false" e1="DDI-PubMed.31002950.s3.e3" e2="DDI-PubMed.31002950.s3.e3" /><pair ddi="false" e1="DDI-PubMed.31002950.s3.e3" e2="DDI-PubMed.31002950.s3.e4" /><pair ddi="false" e1="DDI-PubMed.31002950.s3.e3" e2="DDI-PubMed.31002950.s3.e5" /><pair ddi="false" e1="DDI-PubMed.31002950.s3.e4" e2="DDI-PubMed.31002950.s3.e4" /><pair ddi="false" e1="DDI-PubMed.31002950.s3.e4" e2="DDI-PubMed.31002950.s3.e5" /></sentence><sentence text=" This study investigated the effect of RIF on DTG exposure when dosed at 100 mg once daily, which could provide an easier option than 50 mg twice daily"><entity charOffset="39-41" id="DDI-PubMed.31002950.s4.e0" text="RIF" /><entity charOffset="46-48" id="DDI-PubMed.31002950.s4.e1" text="DTG" /><pair ddi="false" e1="DDI-PubMed.31002950.s4.e0" e2="DDI-PubMed.31002950.s4.e0" /><pair ddi="false" e1="DDI-PubMed.31002950.s4.e0" e2="DDI-PubMed.31002950.s4.e1" /></sentence><sentence text="" /><sentence text="An open label, pharmacokinetic (PK) study was undertaken" /><sentence text=" Healthy HIV-negative subjects received DTG 50 mg for 7 days (PK1), DTG 100 mg for 7 days (PK2), RIF for 14 days, DTG 50 mg + RIF for 7 days (PK3) and DTG 100 mg + RIF for 7 days (PK4)"><entity charOffset="97-99" id="DDI-PubMed.31002950.s7.e0" text="RIF" /><entity charOffset="126-128" id="DDI-PubMed.31002950.s7.e1" text="RIF" /><entity charOffset="164-166" id="DDI-PubMed.31002950.s7.e2" text="RIF" /><entity charOffset="40-42" id="DDI-PubMed.31002950.s7.e3" text="DTG" /><entity charOffset="68-70" id="DDI-PubMed.31002950.s7.e4" text="DTG" /><entity charOffset="114-116" id="DDI-PubMed.31002950.s7.e5" text="DTG" /><entity charOffset="151-153" id="DDI-PubMed.31002950.s7.e6" text="DTG" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e3" e2="DDI-PubMed.31002950.s7.e3" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e3" e2="DDI-PubMed.31002950.s7.e4" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e3" e2="DDI-PubMed.31002950.s7.e0" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e3" e2="DDI-PubMed.31002950.s7.e5" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e3" e2="DDI-PubMed.31002950.s7.e1" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e3" e2="DDI-PubMed.31002950.s7.e6" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e3" e2="DDI-PubMed.31002950.s7.e2" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e4" e2="DDI-PubMed.31002950.s7.e4" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e4" e2="DDI-PubMed.31002950.s7.e0" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e4" e2="DDI-PubMed.31002950.s7.e5" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e4" e2="DDI-PubMed.31002950.s7.e1" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e4" e2="DDI-PubMed.31002950.s7.e6" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e4" e2="DDI-PubMed.31002950.s7.e2" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e0" e2="DDI-PubMed.31002950.s7.e0" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e0" e2="DDI-PubMed.31002950.s7.e5" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e0" e2="DDI-PubMed.31002950.s7.e1" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e0" e2="DDI-PubMed.31002950.s7.e6" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e0" e2="DDI-PubMed.31002950.s7.e2" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e5" e2="DDI-PubMed.31002950.s7.e5" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e5" e2="DDI-PubMed.31002950.s7.e1" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e5" e2="DDI-PubMed.31002950.s7.e6" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e5" e2="DDI-PubMed.31002950.s7.e2" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e1" e2="DDI-PubMed.31002950.s7.e1" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e1" e2="DDI-PubMed.31002950.s7.e6" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e1" e2="DDI-PubMed.31002950.s7.e2" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e6" e2="DDI-PubMed.31002950.s7.e6" /><pair ddi="false" e1="DDI-PubMed.31002950.s7.e6" e2="DDI-PubMed.31002950.s7.e2" /></sentence><sentence text=" Steady-state full DTG PK profiles were evaluated"><entity charOffset="19-21" id="DDI-PubMed.31002950.s8.e0" text="DTG" /></sentence><sentence text="" /><sentence text="DTG geometric mean ratios (GMRs) of PK3/PK1 of maximum concentration (Cmax), area under curve (AUC24h) and 24-h post-dose concentration (C24h) were 0"><entity charOffset="0-2" id="DDI-PubMed.31002950.s10.e0" text="DTG" /></sentence><sentence text="65 [90% confidence interval (CI) 0" /><sentence text="55-0" /><sentence text="75], 0" /><sentence text="44 (90% CI 0" /><sentence text="37-0" /><sentence text="52) and 0" /><sentence text="15 (0" /><sentence text="13-90% CI 0" /><sentence text="17), respectively" /><sentence text=" GMRs of PK4/PK1 Cmax, AUC24h and C24h were 1" /><sentence text="09 (90% CI 0" /><sentence text="97-1" /><sentence text="21), 0" /><sentence text="74 (90% CI 0" /><sentence text="64-0" /><sentence text="86) and 0" /><sentence text="24 (90% CI 0" /><sentence text="20-0" /><sentence text="28), respectively" /><sentence text=" Median C24h of DTG 50 mg + RIF and DTG 100 mg + RIF were 251 (range 129-706) ng/mL and 140 (range 73-426) ng/mL, respectively"><entity charOffset="28-30" id="DDI-PubMed.31002950.s30.e0" text="RIF" /><entity charOffset="49-51" id="DDI-PubMed.31002950.s30.e1" text="RIF" /><entity charOffset="16-18" id="DDI-PubMed.31002950.s30.e2" text="DTG" /><entity charOffset="36-38" id="DDI-PubMed.31002950.s30.e3" text="DTG" /><pair ddi="false" e1="DDI-PubMed.31002950.s30.e2" e2="DDI-PubMed.31002950.s30.e2" /><pair ddi="false" e1="DDI-PubMed.31002950.s30.e2" e2="DDI-PubMed.31002950.s30.e0" /><pair ddi="false" e1="DDI-PubMed.31002950.s30.e2" e2="DDI-PubMed.31002950.s30.e3" /><pair ddi="false" e1="DDI-PubMed.31002950.s30.e2" e2="DDI-PubMed.31002950.s30.e1" /><pair ddi="false" e1="DDI-PubMed.31002950.s30.e0" e2="DDI-PubMed.31002950.s30.e0" /><pair ddi="false" e1="DDI-PubMed.31002950.s30.e0" e2="DDI-PubMed.31002950.s30.e3" /><pair ddi="false" e1="DDI-PubMed.31002950.s30.e0" e2="DDI-PubMed.31002950.s30.e1" /><pair ddi="false" e1="DDI-PubMed.31002950.s30.e3" e2="DDI-PubMed.31002950.s30.e3" /><pair ddi="false" e1="DDI-PubMed.31002950.s30.e3" e2="DDI-PubMed.31002950.s30.e1" /></sentence><sentence text="" /><sentence text="Although there were substantial reductions in DTG C24h when co-administered with RIF, concentrations of both DTG 50 mg and 100 mg once daily with RIF were still above the protein-binding-adjusted IC90 (drug concentration required to inhibit 90% of in-vitro viral replication) of 64 ng/mL"><entity charOffset="81-83" id="DDI-PubMed.31002950.s32.e0" text="RIF" /><entity charOffset="146-148" id="DDI-PubMed.31002950.s32.e1" text="RIF" /><entity charOffset="46-48" id="DDI-PubMed.31002950.s32.e2" text="DTG" /><entity charOffset="109-111" id="DDI-PubMed.31002950.s32.e3" text="DTG" /><pair ddi="false" e1="DDI-PubMed.31002950.s32.e2" e2="DDI-PubMed.31002950.s32.e2" /><pair ddi="false" e1="DDI-PubMed.31002950.s32.e2" e2="DDI-PubMed.31002950.s32.e0" /><pair ddi="false" e1="DDI-PubMed.31002950.s32.e2" e2="DDI-PubMed.31002950.s32.e3" /><pair ddi="false" e1="DDI-PubMed.31002950.s32.e2" e2="DDI-PubMed.31002950.s32.e1" /><pair ddi="false" e1="DDI-PubMed.31002950.s32.e0" e2="DDI-PubMed.31002950.s32.e0" /><pair ddi="false" e1="DDI-PubMed.31002950.s32.e0" e2="DDI-PubMed.31002950.s32.e3" /><pair ddi="false" e1="DDI-PubMed.31002950.s32.e0" e2="DDI-PubMed.31002950.s32.e1" /><pair ddi="false" e1="DDI-PubMed.31002950.s32.e3" e2="DDI-PubMed.31002950.s32.e3" /><pair ddi="false" e1="DDI-PubMed.31002950.s32.e3" e2="DDI-PubMed.31002950.s32.e1" /></sentence><sentence text=" Further studies in HIV-TB co-infected individuals are warranted to confirm these results" /><sentence text="" /></document>